According to IMARC Group’s latest research report, titled “Ophthalmic Viscoelastic Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” offers a comprehensive analysis of the industry, which comprises insights on the ophthalmic viscoelastic devices market growth. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global ophthalmic viscoelastic devices (OVD) market size reached US$ 2.61 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.32 Billion by 2028, exhibiting a growth rate (CAGR) of 4.0% during 2023-2028.
Ophthalmic Viscoelastic Devices Market Outlook:
Ophthalmic Viscoelastic Devices (OVDs) are substances used in ophthalmic surgery to protect the eye’s delicate tissues and improve surgical outcomes. They are gel-like materials that can be injected into the eye to maintain its shape during surgery and then removed at the end of the procedure. OVDs can help protect the cornea and other delicate tissues of the eye from damage during surgery and provide a clear visual field for the surgeon. They can also help prevent complications such as inflammation, infection, and damage to the lens or retina. OVDs are typically made from hyaluronic acid, a natural substance found in the body, or from other synthetic materials. They come in different viscosities or thicknesses, depending on the specific needs of the surgery. OVDs are commonly used in cataract surgery, glaucoma surgery, and other ophthalmic procedures.
Get Free Sample Copy of Report at – https://www.imarcgroup.com/ophthalmic-viscoelastic-devices-market/requestsample
Ophthalmic Viscoelastic Devices Market Trends:
The global market is majorly driven by the rising number of ophthalmic surgeries being performed worldwide. In line with this, the increasing prevalence of eye diseases such as cataracts, macular degeneration, and diabetic retinopathy is significantly contributing to the market growth. Furthermore, the growing geriatric population and escalating demand for cataract surgeries are positively influencing the market. Apart from this, the improving healthcare infrastructure and inflating disposable incomes are catalyzing the market. Moreover, the key players are investing in research and development to introduce innovative OVD products with improved safety and efficacy profiles, further driving the market growth. Besides, the increasing government initiatives to control visual impairment are propelling the market. Additionally, the rapid technological advancements in Ophthalmic Viscoelastic Devices (OVD) are expected to create a positive outlook for the market.
Key Market Segmentation:
Competitive Landscape with Key Players:
- Alcon Inc.
- Altacor Limited
- Bausch Health Companies Inc.
- Bohus Biotech Ab
- Carl Zeiss Meditec Ag
- Cima Technology Inc
- Eyekon Medical Inc.
- Johnson & Johnson
- RUMEX International Co.
- Cohesive Ophthalmic Viscoelastic
- Dispersive Ophthalmic Viscoelastic
- Cataract Surgery
- Glaucoma Surgery
- Corneal Transplant
- Vitreoretinal Surgery
End User Insights:
- Ophthalmic Clinics
Breakup by Region:
- North America (United States, Canada)
- Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
- Market Performance
- Market Outlook
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.